Journal List > Int J Thyroidol > v.9(2) > 1082737

Choi, Kim, Shin, Lee, Heo, Kim, Park, Kim, Lee, Kim, and Kim: Subacute Thyroiditis and Painless Thyroiditis: Clinical Characteristics of 221 Patients Diagnosed between 2009 and 2015

Abstract

Background and Objectives

In the past, subacute thyroiditis causing thyrotoxicosis included both painful and painless subgroup, but it is representative for the painful subacute thyroiditis these days. So we evaluated the clinical and laboratory characteristics of subacute thyroiditis and compared with the painless (silent) thyroiditis, and identified predictive factors of permanent hypothyroidism and recurrence.

Materials and Methods

This was a retrospective case series study analyzing clinical data of 221 consecutive patients diagnosed between 2009 and 2015. Medical records were reviewed for diagnostic route, age distribution, laboratory data, clinical course and long-term follow up outcome.

Results

The mean age was 48 years; female v/s male ratio 3.4:1. Median disease duration was 110 days; mean peak free T4 level was 2.9 ng/dL. 56.7% of painless thyroiditis patients were diagnosed on health checkup or routine thyroid function test with symptoms not typically associated with thyrotoxicosis. Permanent hypothyroidism was not uncommon (11/221; 5.0%). Higher peak thyroid-stimulating hormone (TSH) was associated with permanent hypothyroidism in painless thyroiditis. Lower peak TSH was associated with recurrence rate in both subacute and painless thyroiditis. In painless thyroiditis, short duration of thyrotoxicosis phase was also associated with recurrence rate.

Conclusion

Considerable numbers of painless thyroiditis without symptoms were diagnosed on health checkup. Higher peak TSH was associated with permanent hypothyroidism in painless thyroiditis. Recurrence rate was related with lower peak TSH in both groups.

References

1. Volpe R. Subacute (de Quervain's) thyroiditis. Clin Endocrinol Metab. 1979; 8(1):81–95.
2. Walfish PG. Thyroiditis. Curr Ther Endocrinol Metab. 1997; 6:117–22.
3. Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am. 1998; 27(1):169–85.
crossref
4. Singer PA. Thyroiditis. Acute, subacute, and chronic. Med Clin North Am. 1991; 75(1):61–77.
crossref
5. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003; 348(26):2646–55.
crossref
6. Slatosky J, Shipton B, Wahba H. Thyroiditis: differential diagnosis and management. Am Fam Physician. 2000; 61(4):1047–52. 54.
7. Fatourechi V, Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab. 2003; 88(5):2100–5.
crossref
8. Tikkanen MJ, Lamberg BA. Hypothyroidism following subacute thyroiditis. Acta Endocrinol (Copenh). 1982; 101(3):348–53.
crossref
9. Lio S, Pontecorvi A, Caruso M, Monaco F, D'Armiento M. Transitory subclinical and permanent hypothyroidism in the course of subacute thyroiditis (de Quervain). Acta Endocrinol (Copenh). 1984; 106(1):67–70.
crossref
10. Mizukoshi T, Noguchi S, Murakami T, Futata T, Yamashita H. Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone. Intern Med. 2001; 40(4):292–5.
crossref
11. Kitchener MI, Chapman IM. Subacute thyroiditis: a review of 105 cases. Clin Nucl Med. 1989; 14(6):439–42.
12. Hwang SC, Jap TS, Ho LT, Ching KN. Subacute thyroiditis–61 cases review. Zhonghua Yi Xue Za Zhi (Taipei). 1989; 43(2):113–8.
13. Alfadda AA, Sallam RM, Elawad GE, Aldhukair H, Alyahya MM. Subacute thyroiditis: clinical presentation and long term outcome. Int J Endocrinol. 2014; 2014:794943.
crossref
14. Benbassat CA, Olchovsky D, Tsvetov G, Shimon I. Subacute thyroiditis: clinical characteristics and treatment outcome in fifty-six consecutive patients diagnosed between 1999 and 2005. J Endocrinol Invest. 2007; 30(8):631–5.
crossref
15. Erdem N, Erdogan M, Ozbek M, Karadeniz M, Cetinkalp S, Ozgen AG, et al. Demographic and clinical features of patients with subacute thyroiditis: results of 169 patients from a single university center in Turkey. J Endocrinol Invest. 2007; 30(7):546–50.
crossref
16. Kitaoka H, Sakurada T, Fukazawa H, Suzuki M, Kaise N, Kaise K, et al. An epidemiological study of subacute thyroiditis in northern Japan. Nihon Naibunpi Gakkai Zasshi. 1985; 61(5):554–70.
17. Iitaka M, Momotani N, Ishii J, Ito K. Incidence of subacute thyroiditis recurrences after a prolonged latency: 24-year survey. J Clin Endocrinol Metab. 1996; 81(2):466–9.
crossref
18. Martino E, Buratti L, Bartalena L, Mariotti S, Cupini C, Aghini-Lombardi F, et al. High prevalence of subacute thyroiditis during summer season in Italy. J Endocrinol Invest. 1987; 10(3):321–3.
crossref
19. Saito S, Sakurada T, Yamamoto M, Yamaguchi T, Yoshida K. Subacute thyroiditis: observations on 98 cases for the last 14 years. Tohoku J Exp Med. 1974; 113(2):141–7.
crossref
20. Iitaka M, Momotani N, Hisaoka T, Noh JY, Ishikawa N, Ishii J, et al. TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis. Clin Endocrinol (Oxf). 1998; 48(4):445–53.
crossref
21. Iitaka M, Kakinuma S, Yamanaka K, Fujimaki S, Oosuga I, Wada S, et al. Induction of autoimmune hypothyroidism and subsequent hyperthyroidism by TSH receptor antibodies following subacute thyroiditis: a case report. Endocr J. 2001; 48(2):139–42.
crossref
22. Nakamura S, Saio Y, Suzuki E. Subacute thyroiditis with thyroid-stimulation blocking antibodies: a case report. Endocr J. 1996; 43(2):185–9.
crossref
23. Hnilica P, Nyulassy S. Plasma cells in aspirates of goitre and overt permanent hypothyroidism following subacute thyroiditis. Preliminary report. Endocrinol Exp. 1985; 19(4):221–6.
24. Yamamoto M, Saito S, Sakurada T, Tamura M, Kudo Y, Yoshida K, et al. Recurrence of subacute thyroiditis over 10 years after the first attack in three cases. Endocrinol Jpn. 1988; 35(6):833–9.
crossref
25. Nishihara E, Ohye H, Amino N, Takata K, Arishima T, Kudo T, et al. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med. 2008; 47(8):725–9.
crossref

Fig. 1.
Age distribution of subacute and painless thyroiditis, including postpartum painless thyroiditis patients (postpartum thyroiditis is not included in painless thyroiditis in this figure).
ijt-9-145f1.tif
Table 1.
Laboratory findings of subacute thyroiditis and painless thyroiditis
  All patients
(n=221)
Subacute thyroiditis
(n=64)
Painless thyroiditis
(n=157)
p value
Age (years) (median, range) 48 (23–88) 50.5 (26–76) 47.0 (23–88) 0.078§
Female gender (%) 77 (171/221) 88 (56/64) 73 (115/157) 0.032
ESR (mm/h) (mean±SD) 36.5±33.2 59.2±37.0 27.0±26.7 <0.001§
Anti-TPO antibody (%) 21 (9/43) 14 (2/14) 24 (7/29) 0.693
Anti-TSH receptor antibody (%) 6 (8/133) 3 (1/27) 6 (7/106) >0.999
Peak FT4 (ng/dL) (mean±SD) 2.93±3.3 4.0±5.8 2.5±1.3 0.738§
Duration of thyrotoxicosis (days) 52.9 39.5 59.1 0.038§
Peak TSH (mU/L) (median) 22 21 22 0.057§
Overall duration (days) (median) 110 120 106 0.800§
Permanent hypothyroid (%) 5 (11/221) 8 (5/64) 4 (6/157) 0.304
Recurrence (%) 12 (28/221) 9 (6/64) 14 (22/157) 0.994

§ Mann-Whitney U-test

Chi-squared test by two-sided Pearson' s exact test

Chi-squared test by two-sided Fisher' s exact test

FT4: free thyroxine, TPO: thyroid peroxidase, TSH: thyroid stimulating hormone

Table 2.
Laboratory findings of subacute and painless thyroiditis according to permanent hypothyroidism
  Subacute patients
(n=64)
Permanent hypothyroidism in subacute thyroiditis
(n=5)
p value Painless thyroiditis
(n=157)
Permanent hypothyroidism in painless thyroiditis
(n=6)
p value
Anti-TPO antibody (%) 14 (2/14) 0 (0/2) >0.999 24 (7/29) 66 (2/3) 0.136
Anti-TSH receptor antibody (%) 3 (1/27) 0 (0/1) >0.999 6 (7/106) 33 (1/3) 0.178
Peak TSH (mU/L) (median) 21 35 0.127 22 53 <0.001
Overall duration (days) (median) 120 430 <0.001 106 868 <0.001

Mann-Whitney U-test

Chi-squared test by two-sided Pearson' s exact test

TPO: thyroid peroxidase, TSH: thyroid stimulating hormone

Table 3.
Laboratory findings of subacute and painless thyroiditis according to recurrence
  Subacute thyroiditis patients
(n=64)
Recurrence in subacute thyroiditis
(n=6) (9%)
p value Painless thyroiditis
(n=157)
Recurrence in painless thyroiditis
(n=22) (14%)
p value
Peak TSH (mU/L) 21 12.72 0.007 22 6.38 0.018
Peak FT4 (ng/dL) (mean±SD) 4.0±5.8 2.5±1.3 0.991 2.5±1.3 2.9±1.3 0.086
Duration of thyrotoxicosis (days) (mean) 39.5 56.3 0.325 59.1 48.6 0.001
Overall duration (days) (median) 120 100 0.566 106 112 <0.001

Mann-Whitney U-test

FT4: free thyroxine, SD: standard deviation, TSH: thyroid stimulating hormone

Table 4.
Clinical characteristics of painless thyroiditis patients according to postpartum history
  Postpartum thyroiditis
(n=15)
Non-postpartum painless thyroiditis
(n=142)
p value
Age (years) (median, range) 35 (32–41) 49.5 (23–88) <0.001§
Female gender (%) 100 (15/15) 70 (100/142) 0.012
Anti-TPO antibody>60 (%) 60 (3/5) 17 (4/24) 0.075
Anti-TSH receptor antibody>10 (%) 15 (2/13) 5 (5/93) 0.187
Peak FT4 (ng/dL) (mean±SD) 2.2±1.2 2.7±1.6 0.135§
Peak TSH (mU/L) 36.87 19.93 0.071§
Liver function test abnormality (%) 30 (3/10) 17 (21/124) 0.384
Hypothyroid phase (%) 53 (8/15) 31 (44/142) 0.091
Permanent hypothyroid (%) 20 (3/15) 2 (3/142) 0.012
Recurrent disease (%) 13 (2/15) 14 (20/142) >0.999

§ Mann-Whitney U-test

Chi-squared test by two-sided Pearson' s exact test

Chi-squared test by two-sided Fisher' s exact test

FT4: free thyroxine, SD: standard deviation, TPO: thyroid peroxidase, TSH: thyroid stimulating hormone

TOOLS
Similar articles